Michael G. Rinaldi mostly deals with Microbiology, Fluconazole, Mycosis, Amphotericin B and Itraconazole. His study in Voriconazole, Minimum inhibitory concentration, Broth microdilution, Posaconazole and Aspergillus is done as part of Microbiology. The concepts of his Fluconazole study are interwoven with issues in Azole and Candida albicans.
His Mycosis research includes themes of Pathology, Internal medicine, In vitro and Virology. His Amphotericin B study combines topics in areas such as Trichosporon beigelii, Chromatography, Fungi imperfecti and Aspergillus terreus. His studies deal with areas such as Antibiotics, Etest, Pseudallescheria boydii, Ketoconazole and Pharmacology as well as Itraconazole.
Michael G. Rinaldi mainly focuses on Microbiology, Mycosis, Fluconazole, Amphotericin B and Internal medicine. His biological study spans a wide range of topics, including Dermatology, Pathology, Phaeohyphomycosis and Chemotherapy. His work deals with themes such as Viral disease, Candida glabrata, Candida albicans and Virology, which intersect with Fluconazole.
His Amphotericin B study incorporates themes from Aspergillus fumigatus, Itraconazole, Antibiotics and Aspergillosis. His work focuses on many connections between Itraconazole and other disciplines, such as Pharmacology, that overlap with his field of interest in In vivo and In vitro. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Cardiology.
Michael G. Rinaldi mainly investigates Internal medicine, Cardiology, Microbiology, Platelet reactivity and Mitral regurgitation. The Internal medicine study combines topics in areas such as Gastroenterology and Drug. His work is connected to Posaconazole, Broth microdilution, Voriconazole, Amphotericin B and Caspofungin, as a part of Microbiology.
His Posaconazole study combines topics from a wide range of disciplines, such as In vitro and Pharmacology. His Voriconazole research is multidisciplinary, incorporating elements of Itraconazole and Aspergillosis. Amphotericin B and Immunology are commonly linked in his work.
His primary areas of study are Microbiology, Posaconazole, Internal transcribed spacer, Genetics and Fungi imperfecti. In his research on the topic of Microbiology, Mucor velutinosus is strongly related with Mucorales. The various areas that Michael G. Rinaldi examines in his Posaconazole study include In vitro, Aspergillosis, Pharmacology and Virology.
His studies in Voriconazole integrate themes in fields like Flucytosine, Itraconazole, Drug resistance and Candida krusei. His Drug resistance research is multidisciplinary, relying on both Aspergillus, Aspergillus fumigatus, Minimum inhibitory concentration, Mycosis and Candida spp. His research integrates issues of Trichosporon mycotoxinivorans, Pneumonia, Cystic fibrosis, Pathology and Sputum in his study of Amphotericin B.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
Gregg W. Stone;JoAnn Lindenfeld;William T. Abraham;Saibal Kar.
The New England Journal of Medicine (2018)
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett.
Clinical Infectious Diseases (1997)
Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
John R. Wingard;William G. Merz;Michael G. Rinaldi;Thomas R. Johnson.
The New England Journal of Medicine (1991)
RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE
J H Rex;M G Rinaldi;M A Pfaller.
Antimicrobial Agents and Chemotherapy (1995)
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz.
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
M. Hong Nguyen;James E. Peacock;Arthur J. Morris;David C. Tanner.
The American Journal of Medicine (1996)
Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study
Henry M. Blumberg;Henry M. Blumberg;William R. Jarvis;J. Michael Soucie;Jack E. Edwards.
Clinical Infectious Diseases (2001)
Risk factors for candidemia in neonatal intensive care unit patients
L Saiman;E Ludington;M Pfaller;S Rangel-Frausto.
Pediatric Infectious Disease Journal (2000)
Infections Caused by Scedosporium spp.
Karoll J. Cortez;Emmanuel Roilides;Flavio Quiroz-Telles;Joseph Meletiadis.
Clinical Microbiology Reviews (2008)
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
John H. Rex;Michael A. Pfaller;Thomas J. Walsh;Vishnu Chaturvedi.
Clinical Microbiology Reviews (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: